Publications:5
Video Visit Available
Accepting New Patients
Mount Sinai DoctorsTreats Adults
Accepting New PatientsMary M O'sullivan, MD
Sleep Medicine, Pulmonary Medicine (Lung)
Book an Appointment
About Me
After receiving her medical degree from Cornell University Medical College, Dr. Mary O’Sullivan completed her internship, residency, and pulmonary fellowship training at Mount Sinai St. Luke’s Hospital. Over the past three decades, Dr. Mary O’Sullivan has dedicated a significant portion of her medical career to educating professionals and treating the local communities through spearheading both the asthma and the smoking cessation clinics as well as serving as program director of the chest clinic.
Dr. O’Sullivan’s clinical expertise has had a significant impact on inner-city health in New York City. In response to the high prevalence of inadequately treated asthma patients in the community, Dr. O’Sullivan developed a comprehensive asthma clinic in 1987. In 2000, she similarly spearheaded a smoking cessation program, serving both the Mount Sinai St. Luke’s and Mount Sinai West areas, with the support of the New York City Department Health, Carnegie Mellon Foundation, the James P. Mara Center for Lung Disease, the Margarita Camche Smoking Cessation Fund, and countless volunteers and housestaff. Furthermore, for the last 35 years she has served as the director of chest clinic, the largest medical subspecialty clinic in St. Luke’s Hospital. Dr. O’Sullivan is continually developing innovative approaches to ease access to care, improve efficiency, and incorporate the latest advances into her clinical practice.
A committed and engaged educator, Dr. O’Sullivan precepts categorical medical interns, medical students, pharmacy students, and fellows in all of the aforementioned clinics. She regularly leads smoking cessation trainings for various hospital departments as well as for out-of-network organizations. Dr. O’Sullivan recently became involved the I-ELCAP study and has assisted in incorporating smoking cessation into their lung cancer screening program. Dr. O’Sullivan also runs the ambulatory care conference and pulmonary rounds conference, in which faculty and fellows present challenging cases and discuss treatment options, diagnoses, and new advances. Dr. O’Sullivan serves as consult attending every month and, as such, provides guidance and promotes an environment of inquiry. Furthermore, Dr. O’Sullivan has recently assumed the position as St. Luke’s Asthma representative for the Respiratory Institute. Her dedication to education at all levels within the medical field is unparalleled.
Dr. O’Sullivan’s research interests are varied within the pulmonary field including exploring PDE-4 inhibitor therapy for the treatment of obese, asthma, and ACOS patients, achieving household environmental intervention for inner-city asthma patients through medical-legal collaboration, and improving medical interns’ smoking cessation practice through experience in a medical smoking cessation clinic. Her findings have been presented in scientific journals, at medical and law symposiums and to hospital staff and students. She has published various related articles and influential book chapters.
Dr. O’Sullivan belongs to the American Thoracic Society and the American College of Chest Physicians. She is a member of the advisory boards of the New York Legal Assistance Group and the Lung Cancer Alliance.
Dr. O’Sullivan’s clinical expertise has had a significant impact on inner-city health in New York City. In response to the high prevalence of inadequately treated asthma patients in the community, Dr. O’Sullivan developed a comprehensive asthma clinic in 1987. In 2000, she similarly spearheaded a smoking cessation program, serving both the Mount Sinai St. Luke’s and Mount Sinai West areas, with the support of the New York City Department Health, Carnegie Mellon Foundation, the James P. Mara Center for Lung Disease, the Margarita Camche Smoking Cessation Fund, and countless volunteers and housestaff. Furthermore, for the last 35 years she has served as the director of chest clinic, the largest medical subspecialty clinic in St. Luke’s Hospital. Dr. O’Sullivan is continually developing innovative approaches to ease access to care, improve efficiency, and incorporate the latest advances into her clinical practice.
A committed and engaged educator, Dr. O’Sullivan precepts categorical medical interns, medical students, pharmacy students, and fellows in all of the aforementioned clinics. She regularly leads smoking cessation trainings for various hospital departments as well as for out-of-network organizations. Dr. O’Sullivan recently became involved the I-ELCAP study and has assisted in incorporating smoking cessation into their lung cancer screening program. Dr. O’Sullivan also runs the ambulatory care conference and pulmonary rounds conference, in which faculty and fellows present challenging cases and discuss treatment options, diagnoses, and new advances. Dr. O’Sullivan serves as consult attending every month and, as such, provides guidance and promotes an environment of inquiry. Furthermore, Dr. O’Sullivan has recently assumed the position as St. Luke’s Asthma representative for the Respiratory Institute. Her dedication to education at all levels within the medical field is unparalleled.
Dr. O’Sullivan’s research interests are varied within the pulmonary field including exploring PDE-4 inhibitor therapy for the treatment of obese, asthma, and ACOS patients, achieving household environmental intervention for inner-city asthma patients through medical-legal collaboration, and improving medical interns’ smoking cessation practice through experience in a medical smoking cessation clinic. Her findings have been presented in scientific journals, at medical and law symposiums and to hospital staff and students. She has published various related articles and influential book chapters.
Dr. O’Sullivan belongs to the American Thoracic Society and the American College of Chest Physicians. She is a member of the advisory boards of the New York Legal Assistance Group and the Lung Cancer Alliance.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
About Me
After receiving her medical degree from Cornell University Medical College, Dr. Mary O’Sullivan completed her internship, residency, and pulmonary fellowship training at Mount Sinai St. Luke’s Hospital. Over the past three decades, Dr. Mary O’Sullivan has dedicated a significant portion of her medical career to educating professionals and treating the local communities through spearheading both the asthma and the smoking cessation clinics as well as serving as program director of the chest clinic.
Dr. O’Sullivan’s clinical expertise has had a significant impact on inner-city health in New York City. In response to the high prevalence of inadequately treated asthma patients in the community, Dr. O’Sullivan developed a comprehensive asthma clinic in 1987. In 2000, she similarly spearheaded a smoking cessation program, serving both the Mount Sinai St. Luke’s and Mount Sinai West areas, with the support of the New York City Department Health, Carnegie Mellon Foundation, the James P. Mara Center for Lung Disease, the Margarita Camche Smoking Cessation Fund, and countless volunteers and housestaff. Furthermore, for the last 35 years she has served as the director of chest clinic, the largest medical subspecialty clinic in St. Luke’s Hospital. Dr. O’Sullivan is continually developing innovative approaches to ease access to care, improve efficiency, and incorporate the latest advances into her clinical practice.
A committed and engaged educator, Dr. O’Sullivan precepts categorical medical interns, medical students, pharmacy students, and fellows in all of the aforementioned clinics. She regularly leads smoking cessation trainings for various hospital departments as well as for out-of-network organizations. Dr. O’Sullivan recently became involved the I-ELCAP study and has assisted in incorporating smoking cessation into their lung cancer screening program. Dr. O’Sullivan also runs the ambulatory care conference and pulmonary rounds conference, in which faculty and fellows present challenging cases and discuss treatment options, diagnoses, and new advances. Dr. O’Sullivan serves as consult attending every month and, as such, provides guidance and promotes an environment of inquiry. Furthermore, Dr. O’Sullivan has recently assumed the position as St. Luke’s Asthma representative for the Respiratory Institute. Her dedication to education at all levels within the medical field is unparalleled.
Dr. O’Sullivan’s research interests are varied within the pulmonary field including exploring PDE-4 inhibitor therapy for the treatment of obese, asthma, and ACOS patients, achieving household environmental intervention for inner-city asthma patients through medical-legal collaboration, and improving medical interns’ smoking cessation practice through experience in a medical smoking cessation clinic. Her findings have been presented in scientific journals, at medical and law symposiums and to hospital staff and students. She has published various related articles and influential book chapters.
Dr. O’Sullivan belongs to the American Thoracic Society and the American College of Chest Physicians. She is a member of the advisory boards of the New York Legal Assistance Group and the Lung Cancer Alliance.
Dr. O’Sullivan’s clinical expertise has had a significant impact on inner-city health in New York City. In response to the high prevalence of inadequately treated asthma patients in the community, Dr. O’Sullivan developed a comprehensive asthma clinic in 1987. In 2000, she similarly spearheaded a smoking cessation program, serving both the Mount Sinai St. Luke’s and Mount Sinai West areas, with the support of the New York City Department Health, Carnegie Mellon Foundation, the James P. Mara Center for Lung Disease, the Margarita Camche Smoking Cessation Fund, and countless volunteers and housestaff. Furthermore, for the last 35 years she has served as the director of chest clinic, the largest medical subspecialty clinic in St. Luke’s Hospital. Dr. O’Sullivan is continually developing innovative approaches to ease access to care, improve efficiency, and incorporate the latest advances into her clinical practice.
A committed and engaged educator, Dr. O’Sullivan precepts categorical medical interns, medical students, pharmacy students, and fellows in all of the aforementioned clinics. She regularly leads smoking cessation trainings for various hospital departments as well as for out-of-network organizations. Dr. O’Sullivan recently became involved the I-ELCAP study and has assisted in incorporating smoking cessation into their lung cancer screening program. Dr. O’Sullivan also runs the ambulatory care conference and pulmonary rounds conference, in which faculty and fellows present challenging cases and discuss treatment options, diagnoses, and new advances. Dr. O’Sullivan serves as consult attending every month and, as such, provides guidance and promotes an environment of inquiry. Furthermore, Dr. O’Sullivan has recently assumed the position as St. Luke’s Asthma representative for the Respiratory Institute. Her dedication to education at all levels within the medical field is unparalleled.
Dr. O’Sullivan’s research interests are varied within the pulmonary field including exploring PDE-4 inhibitor therapy for the treatment of obese, asthma, and ACOS patients, achieving household environmental intervention for inner-city asthma patients through medical-legal collaboration, and improving medical interns’ smoking cessation practice through experience in a medical smoking cessation clinic. Her findings have been presented in scientific journals, at medical and law symposiums and to hospital staff and students. She has published various related articles and influential book chapters.
Dr. O’Sullivan belongs to the American Thoracic Society and the American College of Chest Physicians. She is a member of the advisory boards of the New York Legal Assistance Group and the Lung Cancer Alliance.
Language
Position
Hospital Affiliations
- Mount Sinai Morningside
- Mount Sinai Queens
- The Mount Sinai Hospital
- Mount Sinai West
Clinical Focus
- Allergic Cough
- Asthma
- Bronchiectasis
- Bronchiolitis
- Bronchitis
- Chronic Obstructive Pulmonary Disease (COPD)
- Chronic Respiratory Failure
- Collagen-Vascular Associated Lung Disease
- Coronary Artery Disease
Show More
Education
MD, Weill Medical College of Cornell University
Internship, Internal Medicine
Henry Ford Hospital
Residency, Internal Medicine
Henry Ford Hospital
Residency, Internal Medicine
Henry Ford Hospital
Fellowship, Pulmonary and Critical Care Medicine
Henry Ford Hospital
Certifications
American Board of Internal Medicine
Research
Dr. Mary O’Sullivan’s research interests focus on smoking cessation and intervention programs, especially within New York City and State. She has received support from the New York City Department of Health to investigate nicotine replacement therapies, and has also received grants from both the New York City Department of Health and Mental Hygiene’s Bureau of Tobacco Control and the Centers for Disease Control via the Fund for Public Health in New York City to study the impact that smoking cessation clinics have on intern behavior. Additionally, she has led a smoking intervention program for HIV-positive outpatient, and also served as co-investigator for a lung cancer screening study.
Locations
Insurance Information
Accepted insurance may vary by the doctor’s office location. Please contact the office directly to obtain the most up-to-date insurance information.
Patients with Cigna Medicare Advantage or Humana Medicare Advantage insurance: Please read this important message before booking to find out if out-of-network costs may apply to your next visit.
- Mount Sinai Doctors Medicine Multispecialty440 WEST 114TH STREET, SUITE 610, NEW YOUK, NY, 10025
Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).
Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.
Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.
Publications
Selected Publications
- Environmental improvements brought by the legal interventions in the homes of poorly controlled inner-city adult asthmatic patients: A proof-of-concept study. Mary M. O'Sullivan, Julie Brandfield, Sumedh S. Hoskote, Shiri N. Segal, Luis Chug, Ariel Modrykamien, Edward Eden. Journal of Asthma
- Glutathione S-transferase M1 polymorphism and lung cancer risk in African-Americans. Jean G. Ford, Yongliang Li, Mary Margaret O'Sullivan, Rita Demopoulos, Seymour Garte, Emanuela Taioli, Paul W. Brandt-Rauf. Carcinogenesis
- Prophylaxis of AIDS-related Pneumocystis carinii pneumonia with aerosolized pentamidine in a patient with hypersensitivity to systemic pentamidine. Carol G. Baum, J. A. Sonnabend, Mary O'Sullivan. Journal of Allergy and Clinical Immunology
Patient Experience Star Ratings and Comments
The Patient Experience Star Rating reflects our patients’ perception of how well their Mount Sinai provider communicated with them during an office visit. The Star Rating is based on patient responses to three questions on a patient experience survey, a standardized questionnaire sent to verified patients and distributed by a third party vendor, Press Ganey. Responses are measured on a scale of 1 to 5, with 5 being the best score.
Care Provider’s Explanation
Care Provider’s Concern
Likelihood to Recommend Care Provider
Industry Relationships
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. O'Sullivan has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Dr. O'Sullivan has not yet completed reporting of Industry relationships.
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.